2016 Cheat Sheet

Carla Purvis raises the question of hemostasis assay parameters for patients during therapeutic hypothermia. Should we adjust incubation and test temperatures?

Joni Noges asked if there should be a post-plasmapheresis interval before performing the anti-Xa assay.

The issue of monitoring anti-Xa specific DOACs and switching to unfractionated heparin arises again in correspondence between Lance Williams III, MD and Michael Laposata, MD.

Patricia Boyer asks about introductory hemostasis education for undergraduates. George recommends continuing to teach the cascade coagulation model.

Tom Exner asks about weak DRVVT results thay may be possible false positives in VKA therapy.

Suzanne Gorenfield is looking for a clinical assay for endothelial barrier dysfunction.

Pádraig Gunning requests the reference for Michele Drejka's teaching laboratory tilt-tube mixing study protocol.

Does Pradaxa interfere with antiphospholpid antibody assays?

Does CoQ10 affect the anticoagulant properties of Xarelto?

George posts information on the Nijmegen Bethesda assay.

Pages